Search research articles
Contact Us
Filters
Showing results (61-70 of 146) with videos related to
Page
of 15
Sort By:
Gene Therapy
|
April 13, 2021
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma
Sabrina Prommersberger, Michael Reiser, Julia Beckmann, et al.
Journal of Translational Medicine
|
September 14, 2016
In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy
Melanie Bremm, Sabine Huenecke, Olga Zimmermann, et al.
Cytometry. Part B, Clinical Cytometry
|
September 30, 2015
Generation and flow cytometric quality control of clinical-scale TCRαβ/CD19-depleted grafts
Melanie Bremm, Claudia Cappel, Stephanie Erben, et al.
Transfusion
|
June 28, 2016
Optimization of individualized graft composition: CD3/CD19 depletion combined with CD34 selection for haploidentical transplantation
Sabine Huenecke, Melanie Bremm, Claudia Cappel, et al.
International Journal of Molecular Sciences
|
September 28, 2023
Simulating Space Conditions Evokes Different DNA Damage Responses in Immature and Mature Cells of the Human Hematopoietic System
Leonie Handwerk, Heike Katrin Schreier, Daniela Kraft, et al.
Oncotarget
|
October 27, 2017
Hematopoietic transcription factors and differential cofactor binding regulate <i>PRKACB</i> isoform expression
Olga N Kuvardina, Stefanie Herkt, Annekarin Meyer, et al.
Journal of Translational Medicine
|
March 18, 2016
Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure
Christiane Hümmer, Carolin Poppe, Milica Bunos, et al.
Cytotherapy
|
June 15, 2015
Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus
Verena Pfirrmann, Sarah Oelsner, Eva Rettinger, et al.
Plos One
|
January 18, 2019
FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation
Marlene Steiner, Lucas Schneider, Jasmin Yillah, et al.
Haematologica
|
January 16, 2016
Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy
Eva Rettinger, Sabine Huenecke, Halvard Bonig, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 146) with videos related to
Sort By:
Page
of 15
Gene Therapy
|
April 13, 2021
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma
Sabrina Prommersberger, Michael Reiser, Julia Beckmann, et al.
Journal of Translational Medicine
|
September 14, 2016
In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy
Melanie Bremm, Sabine Huenecke, Olga Zimmermann, et al.
Cytometry. Part B, Clinical Cytometry
|
September 30, 2015
Generation and flow cytometric quality control of clinical-scale TCRαβ/CD19-depleted grafts
Melanie Bremm, Claudia Cappel, Stephanie Erben, et al.
Transfusion
|
June 28, 2016
Optimization of individualized graft composition: CD3/CD19 depletion combined with CD34 selection for haploidentical transplantation
Sabine Huenecke, Melanie Bremm, Claudia Cappel, et al.
International Journal of Molecular Sciences
|
September 28, 2023
Simulating Space Conditions Evokes Different DNA Damage Responses in Immature and Mature Cells of the Human Hematopoietic System
Leonie Handwerk, Heike Katrin Schreier, Daniela Kraft, et al.
Oncotarget
|
October 27, 2017
Hematopoietic transcription factors and differential cofactor binding regulate <i>PRKACB</i> isoform expression
Olga N Kuvardina, Stefanie Herkt, Annekarin Meyer, et al.
Journal of Translational Medicine
|
March 18, 2016
Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure
Christiane Hümmer, Carolin Poppe, Milica Bunos, et al.
Cytotherapy
|
June 15, 2015
Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus
Verena Pfirrmann, Sarah Oelsner, Eva Rettinger, et al.
Plos One
|
January 18, 2019
FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation
Marlene Steiner, Lucas Schneider, Jasmin Yillah, et al.
Haematologica
|
January 16, 2016
Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy
Eva Rettinger, Sabine Huenecke, Halvard Bonig, et al.
Page
of 15